Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Maravai Lifesciences Holdings (MRVI) Return on Assets: 2021-2025

Historic Return on Assets for Maravai Lifesciences Holdings (MRVI) over the last 5 years, with Sep 2025 value amounting to -0.24%.

  • Maravai Lifesciences Holdings' Return on Assets fell 1.00% to -0.24% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.24%, marking a year-over-year decrease of 1.00%. This contributed to the annual value of -0.21% for FY2024, which is 13.00% down from last year.
  • As of Q3 2025, Maravai Lifesciences Holdings' Return on Assets stood at -0.24%, which was up 33.37% from -0.37% recorded in Q2 2025.
  • Maravai Lifesciences Holdings' 5-year Return on Assets high stood at 0.27% for Q1 2022, and its period low was -0.37% during Q2 2025.
  • Moreover, its 3-year median value for Return on Assets was -0.12% (2024), whereas its average is -0.13%.
  • Its Return on Assets has fluctuated over the past 5 years, first grew by 17bps in 2022, then declined by 29bps in 2023.
  • Quarterly analysis of 5 years shows Maravai Lifesciences Holdings' Return on Assets stood at 0.25% in 2021, then declined by 3bps to 0.22% in 2022, then dropped by 29bps to -0.07% in 2023, then fell by 15bps to -0.23% in 2024, then decreased by 1bps to -0.24% in 2025.
  • Its Return on Assets was -0.24% in Q3 2025, compared to -0.37% in Q2 2025 and -0.29% in Q1 2025.